Trial Profile
A Phase 2 Randomized, Double-blind, Placebo-controlled Study of the Safety and Efficacy of Talactoferrin Alfa in Patients With Severe Sepsis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 07 Nov 2021
Price :
$35
*
At a glance
- Drugs Talactoferrin alfa (Primary)
- Indications Sepsis
- Focus Therapeutic Use
- Sponsors Agennix AG
- 17 Apr 2014 New trial record